Correlation Between Travere Therapeutics and Nuvation Bio

Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Travere Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on Travere Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Nuvation Bio.

Diversification Opportunities for Travere Therapeutics and Nuvation Bio

0.59

Correlation Coefficient

Travere Therapeutics  Nuvation Bio

Very weak diversification

The 3 months correlation between Travere and Nuvation is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Nuvation Bio go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Nuvation Bio

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.86 times more return on investment than Nuvation Bio. However, Travere Therapeutics is 1.16 times less risky than Nuvation Bio. It trades about 0.16 of its potential returns per unit of risk. Nuvation Bio is currently generating about 0.0 per unit of risk. If you would invest  949.00  in Travere Therapeutics on October 7, 2024 and sell it today you would earn a total of  937.00  from holding Travere Therapeutics or generate 98.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Travere Therapeutics  vs.  Nuvation Bio

Travere Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Nuvation Bio

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nuvation Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nuvation Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Travere Therapeutics and Nuvation Bio

The main advantage of trading using opposite Travere Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.

The idea behind Travere Therapeutics and Nuvation Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.